Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence

Author： Balayssac David Ferrier Jééréémy Descoeur Juliette Ling Bing Pezet Denis Eschalier Alain Authier Nicolas

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.10, Iss.3, 2011-05, pp. : 407-417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical and Preclinical Modulation of Chemotherapy-Induced Toxicity in Patients with Cancer

By Hoekman K.

Drugs, Vol. 57, Iss. 2, 1999-02 ,pp. : 133-155

Adis International

Access to resources Recommend Favorite

Chemotherapy-induced peripheral neurotoxicity

By Cavaletti Guido Marmiroli Paola

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 535-546

Informa Healthcare

Access to resources Recommend Favorite

Role of Mitochondrial Mechanism in Chemotherapy-Induced Peripheral Neuropathy

Current Drug Metabolism, Vol. 19, Iss. 1, 2018-03 ,pp. : 47-54

Bentham Science Publishers

Access to resources Recommend Favorite

Chemotherapy-Induced Peripheral Neuropathic Pain and Rodent Models

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 1, 2016-02 ,pp. : 7-19

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Glutamate in Diabetic and in Chemotherapy Induced Peripheral Neuropathies and its Regulation by Glutamate Carboxypeptidase II

Current Medicinal Chemistry, Vol. 19, Iss. 9, 2012-03 ,pp. : 1261-1268

Bentham Science Publishers

Access to resources Recommend Favorite